Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5386)
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
150,000
Price
$26.72
Total Value
$4.01M
Shares Held After
15,778,113
% of Holdings
0.9%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
275,000
Price
$26.76
Total Value
$7.36M
Shares Held After
15,503,113
% of Holdings
1.7%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
150,000
Price
$26.72
Total Value
$4.01M
Shares Held After
15,778,113
% of Holdings
0.9%
Palisade Bio, Inc. (PALI)
Finley John David — Director
Shares
3,896
Price
$1.75
Total Value
$6.82K
Shares Held After
27,353
% of Holdings
12.5%
Palisade Bio, Inc. (PALI)
Jones Mitchell Lawrence — Chief Medical Officer
Shares
1,989
Price
$1.75
Total Value
$3.48K
Shares Held After
13,263
% of Holdings
13.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
521
Price
$29.64
Total Value
$15.44K
Shares Held After
50,437
% of Holdings
1.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
5,828
Price
$28.94
Total Value
$168.63K
Shares Held After
50,958
% of Holdings
10.3%
Edwards Lifesciences Corp (EW)
Zovighian Bernard J — Director
Shares
19,898
Price
$76.61
Total Value
$1.52M
Shares Held After
83,896
% of Holdings
19.2%
Edwards Lifesciences Corp (EW)
Zovighian Bernard J — Director
Shares
2,532
Price
$77.13
Total Value
$195.29K
Shares Held After
103,794
% of Holdings
2.4%
Cullinan Therapeutics, Inc. (CGEM)
Michaelson Jennifer — Chief Scientific Officer
Shares
416
Price
$12.03
Total Value
$5.00K
Shares Held After
128,219
% of Holdings
0.3%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,000
Price
$26.50
Total Value
$132.50K
Shares Held After
15,700
% of Holdings
31.8%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,700
Price
$24.34
Total Value
$138.74K
Shares Held After
10,700
% of Holdings
53.3%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,000
Price
$23.77
Total Value
$118.85K
Shares Held After
5,000
% of Holdings
100.0%
Twist Bioscience Corp (TWST)
Laponis Adam — Chief Financial Officer
Shares
7,000
Price
$50.00
Total Value
$350.00K
Shares Held After
130,031
% of Holdings
5.1%
Tyra Biosciences, Inc. (TYRA)
Bensen Daniel — Chief Discovery Officer
Shares
5,872
Price
$33.37
Total Value
$195.93K
Shares Held After
146,981
% of Holdings
3.8%
Tyra Biosciences, Inc. (TYRA)
Bensen Daniel — Chief Discovery Officer
Shares
2,128
Price
$31.50
Total Value
$67.04K
Shares Held After
152,853
% of Holdings
1.4%
Hinge Health, Inc. (HNGE)
Perez Daniel Antonio — Director
Shares
166,665
Price
$40.26
Total Value
$6.71M
Shares Held After
0
% of Holdings
100.0%
Neuraxis, INC (NRXS)
Hannasch Brian — 10% Owner
Shares
40,000
Price
$4.92
Total Value
$196.80K
Shares Held After
1,211,522
% of Holdings
3.3%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
3,354
Price
$15.70
Total Value
$52.66K
Shares Held After
428,286
% of Holdings
0.8%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
546
Price
$23.86
Total Value
$13.03K
Shares Held After
651,112
% of Holdings
0.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
547
Price
$23.86
Total Value
$13.05K
Shares Held After
651,114
% of Holdings
0.1%
LABCORP HOLDINGS INC. (LH)
Meltzer Jonathan C — EVP, Operations
Shares
87
Price
$290.42
Total Value
$25.27K
Shares Held After
2,782
% of Holdings
3.0%
ONCOLYTICS BIOTECH INC (ONCY)
Andrews Patricia S — Director
Shares
35,400
Price
$0.86
Total Value
$30.29K
Shares Held After
78,128
% of Holdings
45.3%
ONCOLYTICS BIOTECH INC (ONCY)
Hagerman Allison — VP, Product Development
Shares
10,000
Price
$0.83
Total Value
$8.30K
Shares Held After
115,059
% of Holdings
8.7%
ONCOLYTICS BIOTECH INC (ONCY)
Seizinger Bernd R. — Director
Shares
40,000
Price
$0.85
Total Value
$33.86K
Shares Held After
566,991
% of Holdings
7.1%
ONCOLYTICS BIOTECH INC (ONCY)
Look Kirk — Chief Financial Officer
Shares
12,000
Price
$0.84
Total Value
$10.10K
Shares Held After
287,515
% of Holdings
4.2%
ONCOLYTICS BIOTECH INC (ONCY)
Heineman Thomas Charles — Chief Medical Officer
Shares
12,132
Price
$0.83
Total Value
$10.03K
Shares Held After
282,818
% of Holdings
4.3%
ONCOLYTICS BIOTECH INC (ONCY)
Brown Deborah Margaret — Director
Shares
25,000
Price
$0.85
Total Value
$21.24K
Shares Held After
109,851
% of Holdings
22.8%
ONCOLYTICS BIOTECH INC (ONCY)
Pisano Wayne — Director
Shares
30,000
Price
$0.84
Total Value
$25.34K
Shares Held After
492,414
% of Holdings
6.1%
ONCOLYTICS BIOTECH INC (ONCY)
Kelly Jared — Director
Shares
29,500
Price
$0.84
Total Value
$24.84K
Shares Held After
109,000
% of Holdings
27.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
100
Price
$100.10
Total Value
$10.01K
Shares Held After
118,466
% of Holdings
0.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
800
Price
$98.99
Total Value
$79.19K
Shares Held After
118,566
% of Holdings
0.7%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
400
Price
$97.67
Total Value
$39.07K
Shares Held After
119,366
% of Holdings
0.3%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
292
Price
$96.26
Total Value
$28.11K
Shares Held After
119,766
% of Holdings
0.2%
Avantor, Inc. (AVTR)
SUMME GREGORY L — Director
Shares
100,000
Price
$9.40
Total Value
$940.00K
Shares Held After
400,000
% of Holdings
25.0%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
2,690
Price
$45.00
Total Value
$121.05K
Shares Held After
12,546
% of Holdings
17.7%
Merck & Co., Inc. (MRK)
Guindo Chirfi — Chief Marketing Officer
Shares
10,000
Price
$121.46
Total Value
$1.21M
Shares Held After
60,615
% of Holdings
14.2%
IRIDEX CORP (IRIX)
Dizon Romeo R — Chief Financial Officer
Shares
1,500
Price
$1.43
Total Value
$2.15K
Shares Held After
117,690
% of Holdings
1.3%
WEED, INC. (BUDZ)
BREEN NICOLE M — Director
Shares
37,000
Price
$0.03
Total Value
$1.19K
Shares Held After
30,245,988
% of Holdings
0.1%
EKSO BIONICS HOLDINGS, INC. (EKSO)
ASHER DANIEL — 10% Owner
Shares
20,611
Price
$9.69
Total Value
$199.77K
Shares Held After
192,568
% of Holdings
10.7%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
425,000
Price
$26.67
Total Value
$11.33M
Shares Held After
15,928,113
% of Holdings
2.6%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
425,000
Price
$26.67
Total Value
$11.33M
Shares Held After
15,928,113
% of Holdings
2.6%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
425,000
Price
$26.67
Total Value
$11.33M
Shares Held After
15,928,113
% of Holdings
2.6%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
955
Price
$64.99
Total Value
$62.07K
Shares Held After
1,172,987
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
7,551
Price
$63.73
Total Value
$481.23K
Shares Held After
1,173,942
% of Holdings
0.6%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
11,494
Price
$62.96
Total Value
$723.66K
Shares Held After
1,181,493
% of Holdings
1.0%
IONIS PHARMACEUTICALS INC (IONS)
PARSHALL B LYNNE — Director
Shares
5,000
Price
$82.72
Total Value
$413.59K
Shares Held After
56,344
% of Holdings
8.2%
Zenas BioPharma, Inc. (ZBIO)
Lu Hongbo — Director
Shares
25,985
Price
$22.50
Total Value
$584.66K
Shares Held After
347,968
% of Holdings
7.5%
JOINT Corp (JYNT)
JOBSON CHARLES E — 10% Owner
Shares
448
Price
$8.70
Total Value
$3.90K
Shares Held After
1,639,597
% of Holdings
0.0%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
400
Price
$16.00
Total Value
$6.40K
Shares Held After
156,052
% of Holdings
0.3%
Showing 2751–2800 of 5386 transactions (page 56 of 108)